Terug
Dagbereik
€ 71,39
€ 79,48
52-Weeksbereik
€ 26,20
€ 84,56
Volume
2.140.510
50D / 200D Gem.
€ 71,39
/
€ 55,53
Vorige Slotkoers
€ 79,24
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -15,8 | 0,3 |
| P/B | 4,5 | 2,9 |
| ROE % | -31,6 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 105,63
+44.7%
Low: € 83,00
High: € 137,00
Forward WPA
-€ 4,68
Omzet Sch.
0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,96
-€ 0,96 – -€ 0,96
|
800 M | 4 |
| FY2029 |
-€ 5,90
-€ 5,90 – -€ 5,90
|
200 M | 4 |
| FY2028 |
-€ 6,59
-€ 11,69 – -€ 4,90
|
14 M | 10 |
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -232,60M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-31,57%
ROIC-23,47%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,01
Current Ratio26,57
Interest Coverage0,00
Waardering
P/E Ratio
-15,80
P/B Ratio4,47
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -255,84M |
| ROE | -31,57% | ROA | -27,30% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -232,60M |
| ROIC | -23,47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 26,57 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -15,80 | P/B Ratio | 4,47 |
| P/S Ratio | N/A | PEG Ratio | -0,64 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,04B | Enterprise Value | 3,92B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -255,84M | -182,15M | -83,99M | -39,79M |
| EPS (Diluted) | -4,22 | -3,30 | -1,66 | -0,79 |
| Gross Profit | -1,42M | 0,0 | 0,0 | 0,0 |
| Operating Income | -285,60M | -216,87M | -93,00M | -30,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 937,13M | 753,95M | 401,40M | 152,06M |
| Total Liabilities | 33,25M | 37,16M | 21,49M | 9,98M |
| Shareholders' Equity | 903,88M | 716,79M | 379,91M | 142,08M |
| Total Debt | 8,85M | 11,83M | 2,03M | 0,0 |
| Cash & Equivalents | 131,55M | 141,79M | 118,32M | 151,89M |
| Current Assets | 741,36M | 529,71M | 398,41M | 152,06M |
| Current Liabilities | 27,91M | 28,56M | 20,56M | 9,98M |